What was the market valuation of the US brain ischemia market in 2024?

The market valuation of the US brain ischemia market was $261.35 Million in 2024. Read More

What is the projected market valuation for the US brain ischemia market by 2035?

The projected market valuation for the US brain ischemia market is $543.46 Million by 2035. Read More

What is the expected CAGR for the US brain ischemia market during the forecast period 2025 - 2035?

The expected CAGR for the US brain ischemia market during the forecast period 2025 - 2035 is 6.88%. Read More

Which companies are key players in the US brain ischemia market?

Key players in the US brain ischemia market include Boehringer Ingelheim, Genentech, AstraZeneca, Bristol-Myers Squibb, Roche, Novartis, Pfizer, Eli Lilly and Company, and Sanofi. Read More

What are the segment valuations for Focal Brain Ischemia in 2025?

The segment valuation for Focal Brain Ischemia is projected to range from $150.0 Million to $320.0 Million in 2025. Read More

How does the treatment segment for Angioplasty perform in the US brain ischemia market?

The treatment segment for Angioplasty is expected to range from $40.0 Million to $80.0 Million in 2025. Read More

What is the expected valuation for the Hospitals & Clinics end-user segment in 2025?

The expected valuation for the Hospitals & Clinics end-user segment is projected to be between $150.0 Million and $320.0 Million in 2025. Read More

What is the projected growth for the Global Brain Ischemia segment by 2035?

The Global Brain Ischemia segment is projected to grow from $111.35 Million to $223.46 Million by 2035. Read More

What are the anticipated values for the Others treatment segment in 2025?

The anticipated values for the Others treatment segment are expected to range from $166.35 Million to $353.46 Million in 2025. Read More

What is the expected performance of the Research & Academic Institutes end-user segment by 2035?

The expected performance of the Research & Academic Institutes end-user segment is projected to range from $70.0 Million to $150.0 Million by 2035. Read More

US Brain Ischemia Market

ID: MRFR/MED/18345-HCR

100 Pages

Nidhi Mandole

Last Updated: April 06, 2026

US Brain Ischemia Market Research Report: Size, Share, Trend Analysis By Condition Type (Focal Brain Ischemia, Global Brain Ischemia), By Treatment (Angioplasty, Beta-Blockers, Angiotensin-converting enzyme (ACE) Inhibitors, Others) and By End Users (Hospitals & Clinics, Research & Academic Institutes, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Food, Beverages & Nutrition, BY Condition Type (USD Million)
  1. 4.1.1 Focal Brain Ischemia
  2. 4.1.2 Global Brain Ischemia
2. 4.2 Food, Beverages & Nutrition, BY Treatment (USD Million)
  1. 4.2.1 Angioplasty
  2. 4.2.2 Beta-Blockers
  3. 4.2.3 Angiotensin-converting enzyme (ACE) Inhibitors
  4. 4.2.4 Others
3. 4.3 Food, Beverages & Nutrition, BY End-User (USD Million)
  1. 4.3.1 Hospitals & Clinics
  2. 4.3.2 Research & Academic Institutes
  3. 4.3.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Boehringer Ingelheim (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Genentech (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 AstraZeneca (GB)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Bristol-Myers Squibb (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Roche (CH)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Novartis (CH)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Pfizer (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Eli Lilly and Company (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Sanofi (FR)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY CONDITION TYPE
3. 6.3 US MARKET ANALYSIS BY TREATMENT
4. 6.4 US MARKET ANALYSIS BY END-USER
5. 6.5 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
8. 6.8 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
9. 6.9 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
10. 6.10 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
11. 6.11 FOOD, BEVERAGES & NUTRITION, BY CONDITION TYPE, 2024 (% SHARE)
12. 6.12 FOOD, BEVERAGES & NUTRITION, BY CONDITION TYPE, 2024 TO 2035 (USD Million)
13. 6.13 FOOD, BEVERAGES & NUTRITION, BY TREATMENT, 2024 (% SHARE)
14. 6.14 FOOD, BEVERAGES & NUTRITION, BY TREATMENT, 2024 TO 2035 (USD Million)
15. 6.15 FOOD, BEVERAGES & NUTRITION, BY END-USER, 2024 (% SHARE)
16. 6.16 FOOD, BEVERAGES & NUTRITION, BY END-USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY CONDITION TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY TREATMENT, 2025-2035 (USD Million)
  3. 7.2.3 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Condition Type (USD Million, 2025-2035)

Focal Brain Ischemia
Global Brain Ischemia

Food, Beverages & Nutrition By Treatment (USD Million, 2025-2035)

Angioplasty
Beta-Blockers
Angiotensin-converting enzyme (ACE) Inhibitors
Others

Food, Beverages & Nutrition By End-User (USD Million, 2025-2035)

Hospitals & Clinics
Research & Academic Institutes
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”